| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 21,795,550 | 16,593,986 | 10,604,917 | | Cost of Revenue | 8,621,506 | 6,649,085 | 4,225,027 | | | Gross Profit | 13,174,044 | 9,944,901 | 6,379,890 | | | Operating Expenses | | Research Development | 2,793,192 | 2,119,985 | 1,228,589 | | Selling General and Administrative | 3,748,883 | 2,740,516 | 1,601,305 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 6,631,969 | 5,084,400 | 3,549,996 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (778,373) | 590,783 | 461,301 | | Earnings Before Interest And Taxes | 5,853,596 | 5,675,183 | 4,011,297 | | Interest Expense |
-
| 1,203 | 257 | | Income Before Tax | 5,853,596 | 5,673,980 | 4,011,040 | | Income Tax Expense | 1,626,738 | 1,470,260 | 933,594 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,226,858 | 4,203,720 | 3,077,446 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,226,858 | 4,203,720 | 3,077,446 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,226,858 | $4,203,720 | $3,077,446 |
|
0.14% Nasdaq 
Income Statement
